US Patent 11911388 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Boehringer Ingelheim GmbH

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Boehringer Ingelheim GmbH

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 1323 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
1323 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

87 All APIs, 17 USDMF, 23 CEP/COS, 14 JDMF, 20 KDMF, 34 NDC API, 12 VMF, 2 Listed APIs

87 All APIs
17 USDMF
23 CEP/COS
14 JDMF
20 KDMF
34 NDC API
12 VMF
2 Listed APIs

DEVELOPMENTS

1930 Drugs in Development

1930 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1611 FDF Dossiers, 290 FDA Orange Book, 952 Europe, 120 Canada, 95 Australia, 152 South Africa, 2 Listed Dossiers

1611 FDF Dossiers
290 FDA Orange Book
952 Europe
120 Canada
95 Australia
152 South Africa
2 Listed Dossiers

INSPECTIONS & REGISTRATIONS

103 FDA, 33 EDQM, 3 GDUFA

103 FDA
33 EDQM
3 GDUFA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6BOEHRINGER INGELHEIM

filter Patent Number Reset all filters

6 All

01 611911388

API Patent Reset all filters

6 All

01 6Blank

FDF Patent Reset all filters

6 All

01 6Blank

filter Expiration Date Reset all filters

6 All

01 62030-04-10

01

BOEHRINGER INGELHEIM

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

BePharma

Not Confirmed

BOEHRINGER INGELHEIM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-04-10

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 11911388

Drug Substance Claim :

Drug Product Claim :

Application Number : 208026

Patent Use Code : U-3854

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BOEHRINGER INGELHEIM

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

BePharma

Not Confirmed

BOEHRINGER INGELHEIM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-04-10

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 11911388

Drug Substance Claim :

Drug Product Claim :

Application Number : 201281

Patent Use Code : U-3854

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BOEHRINGER INGELHEIM

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

BePharma

Not Confirmed

BOEHRINGER INGELHEIM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-04-10

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 11911388

Drug Substance Claim :

Drug Product Claim :

Application Number : 201281

Patent Use Code : U-3854

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BOEHRINGER INGELHEIM

BePharma

Not Confirmed

BOEHRINGER INGELHEIM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-04-10

LINAGLIPTIN

US Patent Number : 11911388

Drug Substance Claim :

Drug Product Claim :

Application Number : 201280

Patent Use Code : U-3854

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BOEHRINGER INGELHEIM

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

BePharma

Not Confirmed

BOEHRINGER INGELHEIM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-04-10

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 11911388

Drug Substance Claim :

Drug Product Claim :

Application Number : 208026

Patent Use Code : U-3854

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

BOEHRINGER INGELHEIM

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

BePharma

Not Confirmed

BOEHRINGER INGELHEIM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-04-10

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 11911388

Drug Substance Claim :

Drug Product Claim :

Application Number : 201281

Patent Use Code : U-3854

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.